Literature DB >> 8224104

K252a: a new blocker of the cell-cycle at G1 phase in a human hepatoma cell line.

T Nakayama1, Y Hashimoto, Y Kaneko, M Yoshida, T Beppu, K Ohmi, S Yamashita, Y Nonomura, K Kurokawa.   

Abstract

The administration of 200 nM K252a to HuH7 suppressed the proliferation of the cells almost completely. The uptake of [3H]thymidine was inhibited, and flow cytometry revealed only one peak at 2C on day 3 after treatment with 100 nM K252a. The expression of proto-oncogene c-myc was not reduced. Despite the blockage at G1, both the size of the cells and the amount of cell protein had increased by 4 times by day 3 after treatment with K252a, while the cells secreted albumin and alpha-fetoprotein into the medium as usual. These results show that K252a can increase the cell size of HuH7 without losing its function by blocking the cell cycle at G1 phase.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8224104     DOI: 10.1007/bf01952601

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  26 in total

Review 1.  myc function and regulation.

Authors:  K B Marcu; S A Bossone; A J Patel
Journal:  Annu Rev Biochem       Date:  1992       Impact factor: 23.643

2.  Effect of K252a, a protein kinase inhibitor, on the proliferation of vascular smooth muscle cells.

Authors:  K Ohmi; S Yamashita; Y Nonomura
Journal:  Biochem Biophys Res Commun       Date:  1990-12-31       Impact factor: 3.575

3.  In vitro effects on microtubule dynamics of purified Xenopus M phase-activated MAP kinase.

Authors:  Y Gotoh; E Nishida; S Matsuda; N Shiina; H Kosako; K Shiokawa; T Akiyama; K Ohta; H Sakai
Journal:  Nature       Date:  1991-01-17       Impact factor: 49.962

4.  Potent and preferential inhibition of Ca2+/calmodulin-dependent protein kinase II by K252a and its derivative, KT5926.

Authors:  Y Hashimoto; T Nakayama; T Teramoto; H Kato; T Watanabe; M Kinoshita; K Tsukamoto; K Tokunaga; K Kurokawa; S Nakanishi
Journal:  Biochem Biophys Res Commun       Date:  1991-11-27       Impact factor: 3.575

5.  K-252a, a novel microbial product, inhibits smooth muscle myosin light chain kinase.

Authors:  S Nakanishi; K Yamada; H Kase; S Nakamura; Y Nonomura
Journal:  J Biol Chem       Date:  1988-05-05       Impact factor: 5.157

6.  Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor.

Authors:  K Kelly; B H Cochran; C D Stiles; P Leder
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

7.  Changes in calmodulin and its mRNA accompany reentry of quiescent (G0) cells into the cell cycle.

Authors:  J G Chafouleas; L Lagacé; W E Bolton; A E Boyd; A R Means
Journal:  Cell       Date:  1984-01       Impact factor: 41.582

8.  Sodium butyrate inhibits histone deacetylation in cultured cells.

Authors:  E P Candido; R Reeves; J R Davie
Journal:  Cell       Date:  1978-05       Impact factor: 41.582

9.  Hypomethylation of c-myc and epidermal growth factor receptor genes in human hepatocellular carcinoma and fetal liver.

Authors:  Y Kaneko; M Shibuya; T Nakayama; N Hayashida; G Toda; Y Endo; H Oka; T Oda
Journal:  Jpn J Cancer Res       Date:  1985-12

10.  Ca2+/calmodulin-dependent protein kinase II: localization in the interphase nucleus and the mitotic apparatus of mammalian cells.

Authors:  Y Ohta; T Ohba; E Miyamoto
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.